FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

40630611000001103: Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jun 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2101271000001118 Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2101281000001116 Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fentanyl true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Fentanyl citrate true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Fentanyl 300microgram sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Fenhuma true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 10 tablet Has AMP True Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has AMP True Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start